Funder
Autism Speaks
National Institute on Drug Abuse
National Institute of Mental Health
American Academy of Child and Adolescent Psychiatry
Child Study Center, Yale School of Medicine
Publisher
Springer Science and Business Media LLC
Subject
Developmental and Educational Psychology
Reference51 articles.
1. Allen, M. H., Debanne, M., Lazignac, C., Adam, E., Dickinson, L. M., & Damsa, C. (2011). Effect of nicotine replacement therapy on agitation in smokers with schizophrenia: A double-blind, randomized, placebo-controlled study. American Journal of Psychiatry, 168, 395–399.
https://doi.org/10.1176/appi.ajp.2010.10040569
.
2. Aman, M. G., Singh, N. N., Stewart, A. W., & Field, C. J. (1985). The aberrant behavior checklist: A behavior rating scale for the assessment of treatment effects. American Journal of Mental Deficiency, 89, 485–491.
3. Arnold, L. E., Aman, M. G., Hollway, J., Hurt, E., Bates, B., Li, X., et al. (2012). Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders. Journal of child and Adolescent Psychopharmacology, 22, 198–205.
https://doi.org/10.1089/cap.2011.0056
.
4. Baddick, C. G., & Marks, M. J. (2011). An autoradiographic survey of mouse brain nicotinic acetylcholine receptors defined by null mutants. Biochemical Pharmacology, 82, 828–841.
https://doi.org/10.1016/j.bcp.2011.04.019
.
5. Bagai, K., & Malow, B. A. (2010). A novel approach to treating morning sleep inertia in narcolepsy. Journal of Clinical Sleep Medicine, 6, 77–78.
Cited by
24 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献